SUMMARY:

In 2018, Veritas Capital portfolio company and Oxeon client, Verscend Technologies, completed the acquisition of Cotiviti Holdings, a leading provider of payment accuracy and analytics. The combined company now operates under the Cotiviti name, and is the leading information technology and analytics company transforming the economics of healthcare by providing data services, analytics, and advanced technologies that answer the industry’s most complex challenges. With a focus on reducing risk across all domains of healthcare, Cotiviti’s broad solution suite is designed to help health plans employers, providers, and other risk bearing entities better understand the health and risk of their populations to improve quality, reduce costs, ensure payment accuracy, and support compliance. From effective population health management, quality reporting, revenue accuracy, and chart retrieval to tackling fraud, waste, and abuse, Cotiviti is committed to answering the unique challenges of its clients. Verscend Technologies was formerly known as Verisk Health and is privately-owned by Veritas Capital. Oxeon has done work with the company through its evolution as Verisk Health (division of Verisk Analytics), Verscend Technologies, and Cotiviti.

SEARCHES: Chief Information and Technology Officer (Verisk Health), Executive Vice President of Product (Verisk Health), Chief Executive Officer (Verscend Technologies), Chief Financial Officer (Verscend Technologies), and Senior Vice President of Population Health (Cotiviti)